SNMMI 2023
Investing Into the Future of Theranostics: Aligning Supply to the Clinical Needs
When: Sunday, June 25 | 6:30-7:30pm CST
Where: Lakeside Center, Room E450b, McCormick Place
Overview
This session examines the current landscape and promising future of theranostics, from three distinct but equally important vantage points: The clinician, the radiochemist and the manufacturer. Understanding the interdependencies of these stakeholders will help ensure the value of this critical modality for patients now and well into the future.
For more information or to register click here:
Roger
Estafanos
Session Moderator
General Manager, ITM USA
Dr. Harshad
Kulkarni
Current and Future Utilization of Theranostics: A Clinical Perspective
Chief Medical Advisor, BAMF Health
Neil
Quigley
Synergy Between Lu-177 & Ac-225: A Radiochemistry Perspective
M.Sc, Product Management Radionuclides, ITM
Ram
Mullur
Commercial Availability of Ac-225: A Technology Perspective
M.Sc., MBA, VP-Canadian National Laboratories